Name | Methyl 1-benzyl-N-{[6-(benzyloxy)-5-methoxy-1H-indol-2-yl]carbonyl}-L-histidinate |
---|---|
Synonyms |
L-Histidine, N-[[5-methoxy-6-(phenylmethoxy)-1H-indol-2-yl]carbonyl]-1-(phenylmethyl)-, methyl ester
Methyl 1-benzyl-N-{[6-(benzyloxy)-5-methoxy-1H-indol-2-yl]carbonyl}-L-histidinate |
Description | BMS-466442 is a potent and selective inhibitor of asc-1 (alanine serine cysteine transporter-1), with an IC50 of 11 nM. BMS-466442 inhibits [3H] D-serine uptake into rat brain synaptosomes, with an IC50 of 400 nM. BMS-466442 can be used for schizophrenia research[1][2]. |
---|---|
Related Catalog | |
Target |
IC50: 1 nM (asc-1), 420 nM (dopamine transporter), 6.1 μM (Adrenergic α1D receptor), ≥10 μM (LAT-2), ≥10 μM (ASCT-2)[1] |
In Vitro | BMS-466442 dose-dependently inhibits asc-1 activity in human asc-1 expressing cells and primary cultures with IC50 values of 36.8 ± 11.6 nM and 19.7 ± 6.7 nM, respectively[1]. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 827.3±65.0 °C at 760 mmHg |
Molecular Formula | C31H30N4O5 |
Molecular Weight | 538.594 |
Flash Point | 454.1±34.3 °C |
Exact Mass | 538.221619 |
LogP | 4.33 |
Vapour Pressure | 0.0±3.0 mmHg at 25°C |
Index of Refraction | 1.630 |